4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-029615
Chief Scientific Officer sold 2,373 shares at $25.85 ($61,342)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Beskrovnaya Oxana Chief Scientific Officer | 2024-03-07 | Sale 10b5-1 | −2,373 | $25.85 | $61,342 | 154,433 | D: show line 1 in the form |
| Open-market sales · 2,373 sh · avg $25.85 · $61,342 | |||||||
Loading xslF345X05/ownership.xml…